Taj Medico continues to expand across the Asia Pacific (APAC) region by supplying high-demand pharmaceutical products supported with ACTD dossiers, COPP documentation, WHO-GMP manufacturing, and fast regulatory support for countries including Philippines, Vietnam, Thailand, Malaysia, Indonesia, Cambodia, Myanmar, Sri Lanka, and other ASEAN markets.

With increasing demand for chronic disease medicines, specialty therapies, and innovative formulations in APAC markets, Taj Medico offers a strong portfolio of antidiabetic, cardiovascular, gastroenterology, CNS, anti-infective, hepatology, and specialty products designed for large-scale imports, hospital tenders, and private-label partnerships.


Asia Pacific Product List

Product NameStrengthDosage FormTherapeutic CategoryDossier Status
Semaglutide3 mg, 7 mg, 14 mgTabletAntidiabetic (GLP-1)Under Development
Dapagliflozin + Sitagliptin + Metformin5/50/500 mg, 10/100/1000 mgTabletAntidiabeticReady
Empagliflozin10 mg, 25 mgTabletAntidiabeticReady
Sitagliptin + Metformin50/500 mg, 50/1000 mgTabletAntidiabeticReady
Vildagliptin50 mgTabletAntidiabeticReady
Pregabalin + Methylcobalamin75 mg + 750 mcgCapsuleNeuropathyReady
Obeticholic Acid5 mg, 10 mgTabletHepatologyReady
Tegoprazan50 mgTabletGastroenterologyReady
Esomeprazole20 mg, 40 mgCapsuleAnti-ulcerReady
Linezolid600 mgTabletAnti-infectiveReady
Azithromycin250 mg, 500 mgTabletAntibioticReady
Levofloxacin500 mgTabletAntibioticReady
Gabapentin100 mg, 300 mg, 400 mgCapsuleCNSReady
Levetiracetam500 mg, 1000 mgTabletCNSReady
Rosuvastatin5 mg, 10 mg, 20 mgTabletCardiovascularReady
Telmisartan40 mg, 80 mgTabletAntihypertensiveReady
Sacubitril + Valsartan24/26 mg, 49/51 mgTabletHeart FailureUnder Development
Sildenafil + Dapoxetine50/30 mg, 100/60 mgTabletMen’s HealthReady
Tacrolimus0.2 mg, 1 mgSachetImmunosuppressantReady
Cholecalciferol60,000 IUSachetVitamin SupplementReady

Growing Demand in Asia Pacific Markets

Asia Pacific pharmaceutical markets are rapidly expanding due to rising cases of diabetes, cardiovascular diseases, gastric disorders, infections, neurological disorders, and lifestyle-related illnesses. Countries such as the Philippines, Vietnam, Indonesia, Thailand, and Malaysia are actively seeking reliable pharmaceutical partners with strong regulatory compliance and affordable pricing.

Taj Medico addresses these opportunities through high-capacity manufacturing, fast product registration support, private labeling options, and long-term supply agreements for distributors, hospitals, pharmacies, and government tenders across APAC.


Manufacturing Strength for APAC Supply

Taj Medico’s manufacturing facilities are equipped with:

✔ Tablet manufacturing lines
✔ Capsule filling lines
✔ Sachet production facilities
✔ Dry syrup manufacturing
✔ Sterile injectable units
✔ Stability chambers
✔ In-house quality control laboratories
✔ Large-scale packaging lines

The company supports both regulated and semi-regulated APAC markets with complete documentation including:

  • ACTD dossiers
  • CTD dossiers
  • COPP
  • FSC
  • Stability studies
  • Product registrations
  • Commercial export documentation

Why APAC Buyers Choose Taj Medico

  • Competitive pricing for bulk imports
  • Fast regulatory approvals
  • Wide chronic therapy portfolio
  • Specialty product pipeline
  • WHO-GMP certified production
  • Private labeling support
  • Strong export logistics network

Taj Medico continues to strengthen its presence across the Asia Pacific region by delivering high-quality medicines, regulatory-ready dossiers, and scalable manufacturing solutions for long-term healthcare partnerships.